India axes exports of Gilead Sciences’ remdesivir, plots boost to local production as COVID cases mount: reports
India is one of the world’s biggest manufacturers of drugs and vaccines, but that hasn’t made it immune to COVID-19 supply instability. Now, the government is locking up at least one treatment for itself. As COVID-19 cases mount—and demand for treatments spikes—India has banned exports of Gilead Sciences’ pandemic antiviral remdesivir, Bloomberg reports, citing a statement… Read More »